Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOS
· Real-Time Price · USD
2.15
-0.08 (-3.59%)
At close: Jun 17, 2025, 3:44 PM
2.16
0.70%
After-hours: Jun 17, 2025, 04:00 PM EDT
-3.59% (1D)
Bid | 2.14 |
Market Cap | 12.63M |
Revenue (ttm) | 14.63M |
Net Income (ttm) | -11.24M |
EPS (ttm) | -1.04 |
PE Ratio (ttm) | -2.06 |
Forward PE | -2.27 |
Analyst | Buy |
Ask | 2.29 |
Volume | 65,481 |
Avg. Volume (20D) | 102,493 |
Open | 2.23 |
Previous Close | 2.23 |
Day's Range | 2.14 - 2.20 |
52-Week Range | 1.97 - 6.28 |
Beta | 6.99 |
About VVOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VVOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VVOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-16.99%
Vivos Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
3 months ago
+10.9%
Vivos Therapeutics shares are trading higher after the company announced the expansion of its alliance model to two more Colorado locations.

2 months ago · seekingalpha.com
Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call TranscriptVivos Therapeutics, Inc. (NASDAQ:VVOS ) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ET Company Participants Bradford Amman - CFO, Treasurer & Secretary Kirk Huntsman - Co-Founder, Chairman...